Steris
Prezzo: 207.56Società e modello di business
Steris is a healthcare company specializing in infection prevention, surgical and critical care products, and laboratory services. Its core offerings include sterilization systems, surgical instruments, and endoscopy products. Major business segments encompass Healthcare Products, Healthcare Services, and Life Sciences. The primary revenue sources are derived from the sale of medical devices and services aimed at enhancing patient safety and operational efficiency in healthcare settings.
Profilo di investimento
The investment profile of Steris indicates a focus on stability rather than aggressive growth, appealing more to value and balanced investors. The company offers a modest dividend yield, suggesting some income potential, but the elevated risk factors may deter conservative investors. The stock's performance is characterized by moderate volatility, making it suitable for those with a medium to long-term investment horizon.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- 7.95 OK
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- 6.2% ↑
- Sorpresa EPS
- -1.0% in linea
- Volatilità 20g
- 1.1% stabile
- Rendimento dividendo
- 1.2% moderato ultima data ex-dividendo: 2026-06-08
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-06-09 02:52 | Mantieni | Vendi | Weak momentum and high risk limit upside potential. |
| 2026-06-01 02:51 | Vendi | Mantieni | Weak momentum and high risk overshadow potential upside. |
| 2026-05-08 15:08 | — | Vendi | Weak momentum and high risk; hold for now. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-05-21 12:59 | Piper Sandler | Aggiorna | — → 270 | 216.175 |
| 2026-05-13 10:37 | KeyBanc | Target abbassato | 291 → 269 | 210.85 |
Ancora nulla